BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 7999363)

  • 21. Amino acid residues which distinguish the mitogenic potentials of two FGF receptors.
    Wang JK; Goldfarb M
    Oncogene; 1997 Apr; 14(15):1767-78. PubMed ID: 9150382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rare premalignant prostate tumor epithelial cell syndecan-1 forms a fibroblast growth factor-binding complex with progression-promoting ectopic fibroblast growth factor receptor 1.
    Wu X; Kan M; Wang F; Jin C; Yu C; McKeehan WL
    Cancer Res; 2001 Jul; 61(13):5295-302. PubMed ID: 11431373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligand-specific structural domains in the fibroblast growth factor receptor.
    Wang F; Kan M; Xu J; Yan G; McKeehan WL
    J Biol Chem; 1995 Apr; 270(17):10222-30. PubMed ID: 7730326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Divalent cations and heparin/heparan sulfate cooperate to control assembly and activity of the fibroblast growth factor receptor complex.
    Kan M; Wang F; To B; Gabriel JL; McKeehan WL
    J Biol Chem; 1996 Oct; 271(42):26143-8. PubMed ID: 8824259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
    Krufka A; Guimond S; Rapraeger AC
    Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis.
    Peters KG; Marie J; Wilson E; Ives HE; Escobedo J; Del Rosario M; Mirda D; Williams LT
    Nature; 1992 Aug; 358(6388):678-81. PubMed ID: 1379697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1.
    Rusnati M; Coltrini D; Caccia P; Dell'Era P; Zoppetti G; Oreste P; Valsasina B; Presta M
    Biochem Biophys Res Commun; 1994 Aug; 203(1):450-8. PubMed ID: 8074689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of FGF receptors by mutations in the transmembrane domain.
    Li Y; Mangasarian K; Mansukhani A; Basilico C
    Oncogene; 1997 Mar; 14(12):1397-406. PubMed ID: 9136983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear localization of a complex of fibroblast growth factor(FGF)-1 and an NH2-terminal fragment of FGF receptor isoforms R4 and R1alpha in human liver cells.
    Feng S; Xu J; Wang F; Kan M; McKeehan WL
    Biochim Biophys Acta; 1996 Jan; 1310(1):67-73. PubMed ID: 9244177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A dimeric ternary complex of FGFR [correction of FGFR1], heparin and FGF-1 leads to an 'electrostatic sandwich' model for heparin binding.
    Huhtala MT; Pentikäinen OT; Johnson MS
    Structure; 1999 Jun; 7(6):699-709. PubMed ID: 10404599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complexity of FGF receptors: genetic basis for structural diversity and functional specificity.
    Givol D; Yayon A
    FASEB J; 1992 Dec; 6(15):3362-9. PubMed ID: 1464370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel type I fibroblast growth factor receptor activates mitogenic signaling in the absence of detectable tyrosine phosphorylation of FRS2.
    Lopez ME; Korc M
    J Biol Chem; 2000 May; 275(21):15933-9. PubMed ID: 10748122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternatively spliced FGFR-1 isoforms differentially modulate endothelial cell activation of c-YES.
    Zhang P; Greendorfer JS; Jiao J; Kelpke SC; Thompson JA
    Arch Biochem Biophys; 2006 Jun; 450(1):50-62. PubMed ID: 16631103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
    Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
    Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective inhibition of fibroblast growth factor (FGF)-stimulated mitogenesis by a FGF receptor-1-derived phosphopeptide.
    Dunican DJ; Williams EJ; Howell FV; Doherty P
    Cell Growth Differ; 2001 May; 12(5):255-64. PubMed ID: 11373272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmentally regulated expression and localization of fibroblast growth factor receptors in the human muscle.
    Sogos V; Balaci L; Ennas MG; Dell'era P; Presta M; Gremo F
    Dev Dyn; 1998 Apr; 211(4):362-73. PubMed ID: 9566955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular modeling studies on binding of bFGF to heparin and its receptor FGFR1.
    Lam K; Rao VS; Qasba PK
    J Biomol Struct Dyn; 1998 Jun; 15(6):1009-27. PubMed ID: 9669548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exon III splicing switch of fibroblast growth factor (FGF) receptor-2 and -3 can be induced by FGF-1 or FGF-2.
    Scotet E; Houssaint E
    Oncogene; 1998 Jul; 17(1):67-76. PubMed ID: 9671315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Heterocomplex formation between high and low affinity FGF receptors is mediated by the formation of a FGF dimer].
    Mascarelli F; Courtois Y
    Bull Cancer; 1993 Sep; 80(9):786-98. PubMed ID: 7515734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble forms of the high-affinity fibroblast growth factor receptor in human vitreous fluid.
    Hanneken A; Baird A
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1192-6. PubMed ID: 7730030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.